Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Maekawa

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[HCV replicon]Shinya Maekawa
Journal of Gastroenterology|February 5, 2005
Genetic changes in the interferon sensitivity-determining region of hepatitis C virus (HCV) during the natural course of infection: an implication for the gene function in the role of chronic infectionShinya Maekawa, Nobuyuki Enomoto
Intervirology|January 14, 2010
HCV genetic elements determining the early response to peginterferon and ribavirin therapyNobuyuki Enomoto, Shinya Maekawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[Heterogeneity of HBV genome and its impact on disease progression--Next-generation sequencing analysis focusing on preS region and HBsAg titer]Shinya Maekawa, Nobuyuki Enomoto
Journal of Gastroenterology|July 8, 2018
The "real-world" efficacy and safety of DAAs for the treatment of HCV patients throughout JapanShinya Maekawa, Nobuyuki Enomoto
Journal of Gastroenterology|September 17, 2009
Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis CShinya Maekawa, Nobuyuki Enomoto
Journal of Gastroenterology|December 21, 2013
Once-daily simeprevir in combination with pegylated-interferon and ribavirin: a new horizon in the era of direct-acting antiviral agent therapy for chronic hepatitis CShinya Maekawa, Nobuyuki Enomoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 14, 2004
[Role of interferon-sensitivity-determining region in replication of hepatitis C virus]Shinya Maekawa, Naoya Sakamoto, Nobuyuki Enomoto
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 20, 2024
Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatmentShinya Maekawa, Shinichi Takano, Nobuyuki Enomoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2006
[Interferon resistance and ISDR (interferon sensitivity determining region)]Fumitake Amemiya, Shinya Maekawa, Nobuyuki Enomoto
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[HCV replicon]Shinya Maekawa
Journal of Gastroenterology|February 5, 2005
Genetic changes in the interferon sensitivity-determining region of hepatitis C virus (HCV) during the natural course of infection: an implication for the gene function in the role of chronic infectionShinya Maekawa, Nobuyuki Enomoto
Intervirology|January 14, 2010
HCV genetic elements determining the early response to peginterferon and ribavirin therapyNobuyuki Enomoto, Shinya Maekawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[Heterogeneity of HBV genome and its impact on disease progression--Next-generation sequencing analysis focusing on preS region and HBsAg titer]Shinya Maekawa, Nobuyuki Enomoto
Journal of Gastroenterology|July 8, 2018
The "real-world" efficacy and safety of DAAs for the treatment of HCV patients throughout JapanShinya Maekawa, Nobuyuki Enomoto
Journal of Gastroenterology|September 17, 2009
Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis CShinya Maekawa, Nobuyuki Enomoto
Journal of Gastroenterology|December 21, 2013
Once-daily simeprevir in combination with pegylated-interferon and ribavirin: a new horizon in the era of direct-acting antiviral agent therapy for chronic hepatitis CShinya Maekawa, Nobuyuki Enomoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 14, 2004
[Role of interferon-sensitivity-determining region in replication of hepatitis C virus]Shinya Maekawa, Naoya Sakamoto, Nobuyuki Enomoto
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 20, 2024
Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatmentShinya Maekawa, Shinichi Takano, Nobuyuki Enomoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2006
[Interferon resistance and ISDR (interferon sensitivity determining region)]Fumitake Amemiya, Shinya Maekawa, Nobuyuki Enomoto
Pageof 13